UK scientists designed world’s most sophisticated COVID-19 sequencing system – here’s how they did it

New bioinformatics software and cloud computing approaches developed at BHP founder-member the University of Birmingham have enabled the UK’s COVID-19 genome sequencing effort to be the most sophisticated in the world. The system, called CLIMB-COVID was designed for the COVID-19 Genomics UK (COG-UK) consortium, set up in March 2020 to tackle the huge challenge of rapidly sequencing … Continue reading “UK scientists designed world’s most sophisticated COVID-19 sequencing system – here’s how they did it”

An eight-week gap between Pfizer vaccines is the ‘sweet spot’ for antibody levels and ‘helper’ T cells

A new study carried out in collaboration with BHP founder members the University of Birmingham and University Hospitals Birmingham shows both short and long dosing schedules of the Pfizer COVID-19 vaccine generate strong antibody and T cell immune responses. The study, led by the University of Oxford, in collaboration with the Universities of Birmingham, Newcastle, … Continue reading “An eight-week gap between Pfizer vaccines is the ‘sweet spot’ for antibody levels and ‘helper’ T cells”

People with 5+ symptoms in first week of infection more susceptible to Long Covid

Individuals experiencing five or more symptoms of COVID-19 in the first week of infection are significantly more likely to develop long COVID, irrespective of age or gender, according to a new review led by BHP founder-member the University of Birmingham. The review by the University of Birmingham-led Therapies for Long COVID (TLC) Study Group, published … Continue reading “People with 5+ symptoms in first week of infection more susceptible to Long Covid”

Birmingham kidney patients join Covid-19 clinical trial

A trial that began in Cambridge earlier this year is now rolling out to hospitals across the UK – including BHP founder-member University Hospitals Birmingham – to find out if kidney patients can benefit from additional protection from COVID-19. The trial is investigating if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 … Continue reading “Birmingham kidney patients join Covid-19 clinical trial”

Virtual medical education during the Covid-19 pandemic

During the Covid-19 pandemic, medical students and junior doctors came together globally to help sustain their medical education. Led by Birmingham’s Dr Punith Kempegowda, a Wellcome Trust Clinical Research Fellow and Specialist Registrar in Endocrinology, Diabetes and General Internal Medicine, SIMBA Simulation was born – an interactive simulation-based approach to learning through instant messaging for … Continue reading “Virtual medical education during the Covid-19 pandemic”